ENVARSUS XR
Live / Registered — Registered — partial invalidation of extension of protection (as of 11 Sept 2025)
What this means for you
Registered since 27 Oct 2015. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79165003
- Registration number
- 4839039
- Mark type
- Design + words
- Filed
- 16 Oct 2014
- Published for opposition
- 11 Aug 2015
- Registered
- 27 Oct 2015
- Attorney of record
- Julia Anne Matheson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, immunotherapeutic and immunosuppressive preparations for medical use for treatment of transplantation patients; medical preparations and drug delivery systems, pharmaceutical modified release systems, and controlled release systems, comprised of tablets, [ granules, ] pills [, sachets, powders, capsules, all of the above ] for use in the treatment of [ mental and physical disorders, traumas and emergencies, addictions, aging, allergy, ] immunology, [ burns, ] diseases of the heart and blood vessels, [ dental and gum diseases, skin diseases, nutritional and dietary diseases, ] diseases of the endocrinological system and pancreatic diseases, [ diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, ] neurological diseases, nephrological diseases, [ diseases in the obstetrical and gynaecological field, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and threat, diseases and afflictions in the psychiatric field, ] pulmonological diseases [ and afflictions, rheumatism, urological diseases and afflictions and generalized pain ]
- Class 040 — Treatment of materials: [ Treatment of materials, namely, milling, grinding, mixing, compressing, and melting of pharmaceutical, medicinal, bio technical and bacteriological substances, preparations, formulations and solutions, for use in the pharmaceutical and medical industries ]
- Class 042 — Scientific and technological services: [ Scientific and technological services, namely, clinical testing and technology transfer services as well as research and design in connection therewith, namely, within the medical, pharmaceutical, bio technical and bacteriological areas and providing scientific consultation and information relating thereto; conducting of tests regarding medical applications; packaging design for others; designing and development of medical equipment; designing pharmaceutical medical preparations; development of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consultation and information thereto; materials testing for the pharmaceutical and medical industries ]
- Class 044 — Medical, beauty and agricultural services: [ Medical services; medical and pharmaceutical assistance and consultation, namely, medical and pharmaceutical information services, namely, providing medical and scientific research information in the field of pharmaceuticals ]
Owner
- Veloxis Pharmaceuticals, Inc., DE, US
- Veloxis Pharmaceuticals A/S, DK
- Veloxis Pharmaceuticals A/S, DK-2970 Hørsholm, DK
- Veloxis Pharmaceuticals A/S, DK-2970 Hørsholm, DK
Prior registrations
Prosecution history
- 11 Sept 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 11 Sept 2025 — REGISTERED - PARTIAL SEC 71 ACCEPTED
- 08 Sept 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 May 2025 — TEAS SECTION 71 RECEIVED
- 08 Nov 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 28 Oct 2024 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 17 May 2024 — INTERNATIONAL REGISTRATION RENEWED
- 21 Mar 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 21 Mar 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Mar 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Mar 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Mar 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 25 May 2022 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 25 May 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 25 May 2022 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.